Outstanding full-service IP giant Finnegan, Henderson, Farabow, Garrett & Dunner LLP houses one of the most well-rounded practices in the market. The firm covers a wide range of sectors, and has an excellent track record of performances in the major US venues, including the PTAB, the ITC and the Federal Circuit. A Washington DC trio comprised of managing partner Anand Sharma, chair Mark Sweet and litigation practice chair Frank DeCosta sits at the helm of the practice, which continues to be renowned for its experience handling Hatch-Waxman litigation, but also offers a powerful disputes practice for technology, semiconductor and electronics clients. John Livingstone, who heads the Atlanta office; Robert Shaffer, whose expertise includes medical device, biologics, cutting-edge consumer products, and gaming; and Danielle Duszczyszyn, like Shaffer based in Washington DC and is particularly well-versed in patent cases related to biological products and those arising from the filing of ANDAs, are additional key contacts.
Patents: litigation (full coverage) in United States
Acrox Technologies Co., Ltd.
Advanced Drainage Systems, Inc.
Ajinomoto Co. Inc.
American Regent, Inc.
Asetek Danmark A/S
Bausch Health Companies Inc.
BioDelivery Sciences International (BDSI)
Biogen Idec Inc.
CSL Behring GmbH
Eli Lilly and Company
Globe Union Industrial Corporation
Godbersen Smith Construction Co. Corp d/b/a Gomaco Corporation
Grupo Cosentino SL
Intuitive Surgical Inc.
LG Electronics, Inc.
Monolithic Power Systems, Inc.
Novartis International AG
REC Americas LLC
Siemens Gamesa Renewable Energy, Inc.
TCL Communication Technology Holdings Ltd.
Vifor Pharma Ltd.
Volkswagen Group of America, Inc.
- Achieved a victory for Playtika, which invalidated all five of NexRF’s gaming patents in district court litigation.
- Represented AstraZeneca in a Hatch-Waxman litigation involving patents protecting FARXIGA®, securing a win for the client.
- Defending Nestle over the course of eight years, with a multi-front defense strategy in the district court and the PTAB, against Steuben.
Kirkland & Ellis LLP houses a stellar bench of experienced trial lawyers, including the New York-based Gregory Arovas, Robert Appleby, Joseph Loy, and Todd Friedman; James Hurst, Amanda Hollis, and Bryan Hales in Chicago; Michael De Vries and Ellisen Turner in Los Angeles; Adam Alper in San Francisco; Gregg LoCascio and John O’Quinn in Washington DC; and Jeannie Heffernan in Austin. Operating across the country, the practice is a preferred choice for major industry clients for a wide gamut of patent disputes, litigating cases before district courts, the Federal Circuit, the ITC, the PTAB, and the Supreme Court. The group has particular expertise in the semiconductor, telecommunications, technology, electronics and pharmaceutical industries.
Other key lawyers:
Gregory Arovas; Jeannie Heffernan; Robert Appleby; Joseph Loy; Todd Friedman; James Hurst; Amanda Hollis; Bryan Hales; Michael De Vries; Ellisen Turner; Adam Alper; Gregg LoCascio; John O’Quinn
‘The patent litigation team is extraordinary. They combine deep technical and substantive knowledge with top tier trial skills.’
‘Gregg LoCascio is one of the best trial lawyers I have ever seen. His partner Jeanne Heffernan is whip smart. She may be the only French Literature major I’ve ever known to become a patent litigator, and her extensive soft skills are a fantastic resource.’
‘Russell Levine is an outstanding IP litigator. He knows the relevant law, judges and courts, and the relevant ADR professionals. He thinks like an engineer and speaks their language, which is important for tech companies. He is always thinking a few moves ahead and is a real strategic practitioner.’
‘They are excellent at considering both short-term and long-term when determining litigation strategy. They respond clearly to all questions and involve all team members in the discussion, not just the senior partners.’
‘Mike De Vries is calm, clear in his responses and highly strategic in his analysis. He is responsive when faced with budget concerns even though he is used to dealing with companies with large litigation budgets.’
‘Kirkland argues cases on the merits and advances on that basis. Their ability to win respect from judges is well earned. They brought a diverse set of lawyers with the right skills to our matter.’
Alcon Vision, LLC
AutoStore Technology AS
Boehringer Ingelheim USA
Bristol-Myers Squibb Company
Dr. Reddy’s Laboratories, Inc.
Eagle Pharmaceuticals, Inc.
Eli Lilly & Company
Impax Laboratories, Inc.
Matrixx Initiatives, Inc.
Motorola Solutions, Inc.
Paragon 28, Inc.
Pollard Banknote Limited
Porsche Cars North America
Red Hat, Inc.
Samsung Electronics Co., Ltd.
Sierra Wireless, Inc. and Sierra Wireless America, Inc.
Syngenta Seeds, LLC
TriZetto and Cognizant Technology Solutions
Latham & Watkins LLP‘s patent litigation practice comprises a stellar group of litigators lawyers with significant expertise in high-stakes pharmaceutical and life sciences cases, as well as in disputes from the automotive, technology, and electronics sectors. A regular choice for top-notch names such as Johnson & Johnson, Abbott Laboratories, AbbVie, Jaguar Land Rover Limited, or LG, the team also has an excellent reputation for taking over cases at advanced stages. The group covers all major US patent venues, including district courts, the ITC, and the PTAB. David Callahan, based in the Chicago office; the New York-based Tony Sammi, who joined in September 2021 from Skadden, Arps, Slate, Meagher & Flom LLP; Jennifer Barry (San Diego); Washington DC-based partners Maximilian Grant, Michael Morin, Gabriel Bell, and Matthew Moore; Gregory Sobolski in San Francisco; and Douglas Lumish, who operates from Silicon Valley, are the key names. Recent work highlights include representing AbbVie against Alvotech, who is seeking FDA approval of a biosimilar version of AbbVie’s drug HUMIRA®.
Other key lawyers:
‘One of the best patent teams. Superb knowledge, and provides thoughtful, pragmatic advice.’
‘Deep bench for patent litigation.’
Jaguar Land Rover Limited, and Jaguar Land Rover North America
LG Display, LG Electronics, and Sony
Johnson & Johnson Surgical Vision, Inc. and its subsidiaries, AMO Development, LLC, AMO Manufacturing USA, LLC, and AMO Sales and Service, Inc.
Momentum Dynamics Corporation
Altria Client Services LLC
Philip Morris USA, Inc.; Altria Group, Inc.; Philip Morris International Inc.; Philip Morris Products S.A.
Quinn Emanuel Urquhart & Sullivan, LLP
The ‘smart, aggressive and effective’ patent litigation practice at Quinn Emanuel Urquhart & Sullivan, LLP, ‘earns its fearsome reputation every time’, and has an outstanding track record of victories for major pharmaceutical and technology giants, including Samsung, Qualcomm, or Janssen Pharmaceuticals. The group, which regularly litigates in the main patent venues throughout the country, including the PTAB and the ITC, also shows prowess handling cross-border cases, often joining forces with its colleagues abroad and with firms from other jurisdictions. Fronting the practice are Charles Verhoeven and Sean Pak in San Francisco; David Nelson in Chicago; Edward DeFranco in New York; and Silicon Valley’s Victoria Maroulis and Tigran Guledjian. Kevin Johnson, who is also based in California, is another key contact of the practice. Claude Stern, Frederick Lorig, and Peter Armenio left the firm.
Other key lawyers:
‘Smart, aggressive and effective. QE earns its fearsome reputation every time.’
‘The Quinn Emmanuel IP Litigation Team are dogged advocates for their clients. They are tenacious in their representation, always thinking multiple steps ahead. They are very knowledgeable in the area of Hatch-Waxman law and of the pharmaceutical industry.’
Allergan USA and Ironwood Pharmaceuticals
Becton, Dickinson & Co.
- Acting as lead counsel for Bard in two related patent infringement suits against Medical Components, Inc. (“MedComp”) relating to power injectable vascular access ports.
- Acting as lead counsel for Janssen in series a Hatch-Waxman patent litigation relating to Janssen’s blockbuster diabetes drugs INVOKANA®, INVOKAMET®, and/or INVOKAMET XR, which together have sales in excess of $1bn.
- Represented Samsung against Evolved Wireless LLC (“Evolved”) in a patent infringement action on the District of Delaware, relating to five patents that Evolved alleges are essential to practicing the LTE cellular standard.
WilmerHale’s renowned patent litigation practice garners praise for being ‘capable of handling the biggest, most complex, and most important patent litigation matters’. The firm earns additional plaudit for having a ‘great bench from top to bottom’, consisting of experienced litigators as well as technically trained attorneys who hold degrees in areas such as engineering, computer science, biology and chemistry degrees. A popular choice for technology and life sciences clients, including biotechnology and pharmaceutical players, as well as for semiconductor companies, the team offers strong cross-border capabilities, and has a solid track record litigating cases before the district courts, the Federal Circuit, the Supreme Court, and the ITC. Lisa Pirozzolo (Boston) and Mark Selwyn (Palo Alto) co-head the IP litigation department, while Emily Whelan and Joseph Haag, based in Boston and Palo Alto respectively, chair the broader IP practice. Other noted practitioners include seasoned Boston-based litigator William Lee; Sonal Mehta, who has a particular focus on technology companies; Amy Wigmore (DC); Denver’s Mindy Sooter; Robert Gunther; Brittany Amadi; and Omar Khan. Donald Steinberg retired in 2021.
Lisa Pirozzolo; Mark Selwyn; Emily Whelan; Joseph Haag
Other key lawyers:
William Lee; Sonal Mehta; Amy Wigmore; Mindy Sooter; Robert Gunther; Brittany Amadi; Omar Khan
‘Capable of handling the biggest, most complex, and most important patent litigation matters.’
‘Outstanding talent development, camaraderie between senior partners to achieve best teams and outcomes for clients, rather than internal competition and sharp elbows.’
‘They have a great bench from top to bottom, which is rare to find. They also have a deep knowledge within the firm that can be leveraged to answer just about any question.’
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Gilead Sciences, Inc.
Lenovo Group Limited
Roche Molecular Systems, Inc.
Comcast Cable Communications
- Successfully defended Intel against a $3bn claim from VLSI regarding microprocessor patents infringement.
- Secured a victory for Bristol-Myers Squibb and Pfizer when the US Court of Appeals for the Federal Circuit affirmed a district court decision holding that the patents that cover the drug Eliquis® are valid and infringed by all generics challenging them.
Gibson, Dunn & Crutcher LLP‘s impressive patent litigation team appeals to clients for its long track record of acting in challenging IP cases, representing leading global companies, especially from the pharmaceutical and technology sectors. Names such as Fitbit, EMC, EMD Serono and Pfizer, T-Mobile, Novartis, and Peloton are among the group’s enviable client roster. The core of the practice is based in New York, where Josh Krevitt (also present in Palo Alto), Jane Love, Kate Dominguez, and Benjamin Hershkowitz are the main contacts. Ernest Hsin in San Francisco and Wayne Barsky in Los Angeles are other key contacts. Additionally, the team offers robust ITC experience, which complements the firm’s strong district court, Federal Circuit and PTAB practice.
EMC (part of Dell)
EMD Serono and Pfizer
Smith + Nephew/ArthroCare
Irell & Manella LLP
Seasoned litigator Morgan Chu, who has an impressive track record of handling complex patent disputes, heads the practice at Irell & Manella LLP, closely supported by his bench of lawyers in Los Angeles and Newport Beach, which includes Benjamin Hattenbach, Jonathan Kagan, Jason Sheasby and Lisa Glasser. The group has litigated patents from nearly every technology discipline, including software, semiconductors, biotechnology, pharmaceuticals, medical products, telecommunications, video games and e-commerce, and offers a solid experience in federal court disputes with skilled PTAB litigators. The firm further strengthened its national footprint in 2021 with the opening of an office in Washington DC, led by Andrei Iancu, former director of the US Patent and Trademark Office, who rejoined the firm in April 2021. Alan Heinrich, Annita Zhong, and Rebecca Carson are other names to note.
Other key lawyers:
USAA (United States Automobile Association)
Johnson & Johnson
Banc of California
- Obtained a $2.2bn jury verdict for VLSI Technology LLC in a suit against Intel Corporation, involving two patents on technology used in Intel’s microprocessors.
- Secured a $300bn jury award for PanOptis in a suit against Apple involving patents essential to LTE technology used in iPhones and cellular-enabled iPads and watches.
- Successfully defended Juniper Networks against a cybersecurity patent infringement lawsuit brought by Finjan.
Drawing from its strong global and US presence, Jones Day is a solid choice for complex cross-border IP disputes. The practice is frequently sought out by leading pharmaceutical and life science companies for the protection of their patents, and maintains a busy caseload in the technology, electronics, software and consumer product sectors. The group regularly acts before the country's most relevant venues, with a good track record before the federal circuit, PTAB, and a growing ITC practice. Steering the team are the Cleveland-based David Maiorana, co-chair of the IP litigation practice; and Anthony Insogna in San Diego, who is currently chair of the firm’s global IP department and is particularly well versed in representing pharmaceutical and biotech companies. Andrea Jeffries (Los Angeles); Jones Day (Chicago); Sarah Geers (New York); and Greg Lanier (Silicon Valley) are other key names of the practice.
Johnson & Johnson
Merck & Co., Inc.
NXP Semiconductors N.V.
Qualcomm R. J.
Reynolds Tobacco Company
Takeda Pharmaceutical Company
- Secured a victory at the ITC representing R.J. Reynolds against Philip Morris International and Altria regarding the infringement of vaping patents.
- Advised SK Innovation on the settlement of a global patent infringement dispute with LG Chem Ltd. involving lithium-ion battery technology used in electric vehicles.
- Represented Regenxbio in an arbitration against Regenxbio’s licensee Abeona Therapeutics Inc.
A ‘deep bench of experienced patent litigators’ make up Paul Hastings LLP‘s practice which is frequently the first choice for leading drug makers enforcing or defending key patents. Life sciences and pharmaceutical litigation, including biotech disputes, remain the core strengths of the team, but technology, semiconductor, and consumer product clients also frequently seek out the group for its success rate in these sectors. Clients include Samsung, Merck, AbbVie/Allergan, Eli Lilly, Johnson & Johnson, Google, Mitsubishi Tanabe, TikTok, L’Oréal, and FitBit. New York-based attorneys Eric Dittmann and Bruce Wexler, who is renowned for his superb life sciences practice, co-head the global IP practice in conjunction with Washington DC’s Naveen Modi, a ‘savvy litigator’ who drives the firm’s notable post-grant review practice. Robert Unikel in Chicago, California’s Yar Chaikovsky and Phillip Ou, and senior associate David Okano are other highlighted members of the practice. The Palo Alto office was reinforced in 2021 with the arrival of partner Matthias Kamber from Keker, Van Nest & Peters LLP, The Washington DC office grew with the addition of ITC specialist Kecia Reynolds from Pillsbury Winthrop Shaw Pittman LLP.
‘This firm has the capability of taking on and succeeding at complex patent cases. They consistently produce high-quality work and achieve great results.’
‘I’ve worked primarily with Yar Chaikovsky, who has a great command of patent law and strategy for patent litigation. He has a passion for winning. Phil Ou is a junior partner who has done a very good job. David Okano is a great, aggressive senior associate.’
‘Naveen Modi is a savvy litigator who has a unique ability to see around corners. He’s simply the finest and his team is excellent.’
‘Naveen Modi’s approach to a patent litigation matter is always balanced and client-centric. He places the client’s business goals above all else, and works tirelessly to achieve those goals.’
‘Robert Unikel is an excellent lead with a measured approach to litigation issues. He builds around him teams that are diligent, thoughtful, good communicators, and strong advocates for his clients. It’s a pleasure to work with him and his teams.’
‘Paul Hastings has a deep bench of experienced patent litigators.’
‘Eric Dittman is a subject matter expert who is very practical to the needs of the client. Very easy to work with.’
‘The team keeps a view on the client’s overall business goals rather than just playing to ‘win’ the litigation.’
Align Technology, Inc.
Johnson & Johnson
Daiichi Sankyo Co., Ltd.
Mitsubishi Tanabe Pharma Corporation
Merck & Co., Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Actelion Pharmaceuticals Ltd.
- Acted for Mitsubishi Tanabe Pharma Corporation to enforce the key Orange Book patents covering the endocrinology drugs Invokana® and Invokamet® against five generic competitors.
- Representing Daiichi Sankyo in a high-profile, multi-jurisdictional dispute, most recently as a plaintiff in a related APA action filed in the Eastern District of Virginia in 2021.
- Leading Google’s defense of nine separate patent infringement cases brought by Plaintiff Uniloc in the Eastern District of Texas relating to video conferencing features, video encoding, and text message attachments among other things.
Nicholas Groombridge, a renowned patent litigator who also ‘stands out as an excellent communicator and strategist’, leads the practice at Paul, Weiss, Rifkind, Wharton & Garrison LLP, which has particularly strong expertise before the PTAB, complemented by a solid experience in other US venues such as the Federal Circuit and the ITC. Excelling across a wide range of fields, including pharmaceuticals, biotechnology, medical devices, computer software and hardware, electronics, telecommunications and financial services, the practice includes deputy chair Catherine Nyarady, Jennifer Wu, and Eric Alan Stone in New York. Steven Baughman, ‘the partner to rely on in a technical patent case’, and counsel Megan Raymond, who handles ‘difficult arguments and witnesses with grace and effectiveness’, are based in the Washington DC office.
‘Strategic thinkers who involve the right practice groups to not only focus on winning a case, but winning the bigger picture.’
‘Nicholas Groombridge stands out as an excellent communicator and strategist. He has the right combination of experience and willingness to try new strategies.’
‘The team (Steve Baughman, Megan Raymond) wins at an extraordinarily high rate. Judges, juries and PTAB administrative law judges trust and enjoy their work, because they are thoroughly prepared, accurate, and understandable. Their technical skills combined with first rate legal analysis are the best. The diverse ethnic and gender composition of this patent team is a wonderful bonus.’
‘Steve Baughman is the partner to rely on in a technical patent case, because he masters the facts and the law to produce outstanding arguments. Megan Raymond is a rising star who can handle difficult arguments and witnesses with grace and effectiveness .’
‘Excellent understanding of technical details, strong oral advocacy skills and trial experience.’
‘Eric Stone is an excellent advocate, with strong presence and deep understanding of technical issues.’
Earning plaudit for approaching the work with ‘extreme thoroughness and high level of coordination’, Washington DC-based firm Williams & Connolly LLP is well known for representing clients from the pharmaceutical and biotech, electronics and software fields, primarily in Hatch-Waxman litigation, licensing disputes, as well as in trade secret litigation. The practice is jointly headed by David Berl, who has a strong focus on biotech and small molecule pharmaceuticals; and Jessamyn Berniker, who has extensive experience in Hatch-Waxman cases. They are closely supported by key practitioners Bruce Genderson, who is lauded as one of the ‘best trial attorneys in the IP space’, ‘excellent first chair trial attorney’ Stanley Fisher; Andrew Trask, who focuses on patent appeals; Adam Harber; Thomas Selby; and Dov Grossman.
Other key lawyers:
‘Andrew Trask is a rising star litigator.’
‘Extreme thoroughness and high level of coordination.’
‘Bruce Genderson: a true professional. One of the best trial attorneys in the IP space in the US. Bruce is a great mentor and teacher. Stan Fischer: excellent first chair trial attorney.’
Teva Pharmaceuticals International GmbH and Cephalon, Inc.
Merck Sharp & Dohme Corp.
Norton (Waterford) Ltd.
- Secured a trial victory for AstraZeneca in a patent case concerning the company’s Symbicort product, an inhaler treatment for asthma and chronic obstructive pulmonary disease.
- Successfully represented Dropbox in patent infringement litigation brought by Synchronoss Technologies, Inc. alleging that Dropbox’s products infringe three US-based synchronization-related patents.
- Trial and appellate victory on behalf of Teva Pharmaceuticals in an ANDA litigation concerning Teva’s flagship branded product, Bendeka®.
Arnold & Porter’s patent litigation practice is jointly headed from Washington DC by the reputed Matthew Wolf, who has an established track record in patent disputes across the district courts, the ITC, and multiple appellate courts; and Dina Hayes, a skilled patent litigator with a particular expertise in the technology, pharmaceutical, life sciences and consumer products sectors. Further expertise is brought in by Deborah Fishman in Silicon Valley; and San Francisco’s Michael Berta, a regular advisor for Adobe, Google or Crocs, who is experienced in both patent and trade secret litigation. The group, which is also well-versed in Hatch-Waxman litigation, also operates from Los Angeles, New York, Denver and Chicago.
Matthew Wolf; Dina Hayes
Boston Scientific Corp.
- Represented Hologic in patent litigation involving uterine ablation technology that resulted in favorable jury verdict and as appellate counsel, including before the US Supreme Court in securing opinion upholding assignor estoppel doctrine.
- Successfully represented Sanofi and Regeneron in litigation against Amgen, invalidating Amgen’s patents and preserving Sanofi and Regeneron’s ability to continue to market its cholesterol-reducing drug Praluent.
- Represented Crocs in ITC proceedings following a remand from the Federal Circuit, defending Crocs’ patents against claims of inequitable conduct and securing the issuance of a general exclusion order to bar the importation of infringing products.
Baker Botts L.L.P. houses a sturdy and active patent litigation practice, which garners praise for its ‘excellent technical chops; litigation savvy; first-rate work product; and excellent oral advocacy’. The group is particularly skilled in acting for defendants side and handling PTAB proceedings in addition to shouldering a significant Federal Circuit caseload, consistently achieving ‘great results’. The technology, telecommunications, and electronics are core focus sectors. New York's Robert Scheinfeld and the Dallas-based Christa Brown-Sanford act as chair and deputy of the IP group, while Douglas Kubehl, also in Dallas, and Roger Fulghum in New York co-head the IP litigation practice. Robert Maier, Sarah Guske, who stands out for her ‘intense strategic approach to every aspect of litigation’, Eliot Williams, ‘an excellent advocate in PTAB hearings’, ‘outstanding strategist’ Hopkins Guy, Peter Kang, who has a focus on major Korean companies which ties in well with the firm's solid Asia-Pacific region coverage, Jennifer Tempesta, and Syed Fareed are other key names of the department.
Other key lawyers:
‘The Baker Botts IP Team knows our industry and our company better than any other firm. They bring the whole package: excellent technical chops; litigation savvy; first-rate work product; and excellent oral advocacy.’
‘Hopkins Guy is at the top of his game. He’s a seasoned trial lawyer and an excellent patent lawyer. He provides excellent tactical advice and is excellent in court. Eliot Williams is an excellent advocate in PTAB hearings and Federal Circuit arguments.’
‘The Baker Botts litigation team is very capable both in the various technologies and in all the legal issues. They are focused on strategy from the beginning and consistently achieve great results.’
‘Hopkins Guy is an outstanding strategist, has a deep understanding of the law and one of the best attorneys I know on his feet in depositions or court.’
‘Sarah Guske is extremely dedicated and hard-working and she’s also a pleasure to work with. She is funny, smart and thinks through even the minutiae with a strategic mindset. She is a fantastic attorney. Sarah stands out because of her responsiveness, how relationship-minded she is, and her intense strategic approach to every aspect of litigation.’
Samsung Electronics Co., Ltd.
AT&T Mobility LLC
Oxford Nanopore Technologies Limited
DISH Technologies L.L.C and Sling TV L.L.C.
Kiss Nail Products, Inc.
CMC Materials, Inc.
Toyota North America Motor Inc.
Fujifilm Holdings Corporation (and subsidiaries).
Guangdong Mic-Power New Energy Co. (“Mic-Power”), Audio Partnership LLC and Audio Partnership PLC D/B/A Cambridge Audio (“Cambridge Audio”), GN Audio A/S and GN Audio USA Inc. D/B/A Jabra (“Jabra”), and PEAG, LLC, D/B/A JLab Audio (“JLab”)
- Secured a patent jury trial for Oxford Nanopore, the developer of a new DNA-sequencing platform.
- Achieved a win for Qualcomm at the Federal Circuit Court of Appeals regarding the validity of its patents in inter partes reviews (IPRs) filed by Apple at the Patent Trial & Appeal Board (PTAB).
- Obtained a favorable ITC initial determination for CMC in a patent infringement case against DuPont de Nemours.
Hailed for providing ‘tailor-made guidance’, Cooley LLP fields a comprehensive IP practice for major life sciences and technology clients, including Facebook, Microsoft, and Qualcomm, with a solid patent litigation practice which operates from Washington DC, New York, Palo Alto, San Francisco and Reston, VA. Stephen Smith, the go-to advisor for several big names from the technology space, is in charge of steering the group. Heidi Keefe , ‘a great advocate and strategic adviser’ with a strong expertise in technology sector patent cases; Jonathan Davies, who specializes in pharma and biotechnology disputes; and experienced life sciences patent litigator Sanya Sukduang are among the main contacts. The practice, which demonstrates strength in all US patent venues, also includes Erik Milch, Adam Pivovar, Matthew Brigham and Jon Graves.
Other key lawyers:
‘Stephen Smith and his team deliver best-in-class expert advice in the industry. He understands our company and its culture to provide tailor-made guidance to our patent litigation strategy.’
‘Great job on IPRs. Good strategic advice.’
‘Heidi Keefe is a great advocate and strategic adviser. She is experienced, confident, and not afraid to give you her unvarnished blunt opinion.’
Content Square SAS
BAI Intelligence LLC
Biolux Research Holdings, Inc.
DalCor Pharma UK
Usher III Initiative, Inc.
- Representing the University of Pennsylvania in a patent infringement action in the District Court for the Eastern District of Pennsylvania against Eli Lilly, ImClone and Bristol Myers Squibb.
- Defended Spin Master Corp. and its affiliates Spin Master Ltd. and Swimways Corporation in a lawsuit filed by Tai Matlin and James Waring in U.S. District Court for the Northern District of Illinois and in two appeals to the Seventh Circuit.
- Defending Liquidia Technologies in an ongoing patent infringement matter brought by United Therapeutics Corporation based on Liquidia’s seeking FDA approval for a formulation of treprostinil to treat pulmonary arterial hypertension.
DLA Piper LLP (US)’s sizable patent litigation group is a powerful force in the US, frequently praised for its ‘committed and dedicated team’, as well as for its ‘vast experience’. The practice is a preferred choice for a number of major international and domestic companies thanks to its experience in the main US patent litigation forums as well as for its solid cross-border capabilities, which it puts to use in other key patent jurisdictions such as the UK and Germany. Cases related to the technology, life sciences, and consumer products sectors account for a particularly significant portion of the caseload. The California-based team of Mark Fowler, vice chair of the intellectual property and technology practice; Sean Cunningham, the chair of the US patent litigation team, and Erin Gibson, who is particularly skilled in ITC proceedings, are the key names of the department. Washington DC’s Kathryn Riley Grasso, who according to a client is ‘able to elevate the performance of the entire team’, and Delaware’s Brian Biggs, who was promoted to partner in 2021, are other key contacts. The practice was further reinforced with the arrival in May and June 2021 of partners Jennifer Nall (Austin) and Helena Kiepura (DC), who joined from Baker Botts L.L.P. and Kirkland & Ellis LLP respectively.
Other key lawyers:
Kathryn Riley Grasso; Erin Gibson; Brian Biggs; Paul Steadman
‘Vast experience in a wide array of cases. Committed and dedicated team members. Understand the business demands of clients. Trial experience.’
‘Collaborative efforts. Team players. Individual attorneys are able to elevate the performance of the entire team. Katie Grasso especially stands out in this regard.’
‘Erin Gibson provides reassuring leadership, is technically adept, is communicative, and is always strategic with her approach. Sean Cunningham sees the big picture, works well with the internal business and provides practical strategy to ensure the case is always well-positioned. Brian Erickson works well with our internal clients, and has deep technical and legal knowledge which makes him an effective advocate.’
‘They understand our business and our goals, and they work well with our internal business and engineering teams. DLA shines in their practical approach to litigation and collaborates with us to be efficient and effective.’
‘Paul Steadman is a very powerful, reliable and experienced trial lawyer, especially before judge and jury. He is outstanding to focus on the most important issues in a complicated case in his argument and lead to the conclusion. Paul is the last attorney that we would want argue against in the court as opponent counsel.’
‘DLA Piper has a very powerful IP litigation team that quickly creates a strategy and assigns attorneys who are experienced and familiar with the technologies relating to an IP litigation or ITC investigation.’
‘The team has strengths in the Japanese automotive industry and knows supplier chain structures well.’
‘Matthew Satchwell is client-oriented and a great litigator and negotiator.’
Lenovo Group Ltd. and Lenovo (United States) Inc.
Motorola Mobility LLC
Toyota Motor Corporation
- Representing Microsoft in a seven-patent infringement lawsuit regarding certain remote desktop and graphics functionality.
- Represent Lenovo and Motorola Mobility in a five-patent infringement lawsuit regarding USB and charging technologies throughout the computing industry.
- Represented Pfizer as co-lead counsel in several Hatch-Waxman litigations relating to XELJANZ. XELJANZ (tofacitinib) is the first FDA-approved oral medication of its kind (JAK inhibitor) that treats adults with moderate to severe rheumatoid arthritis, active psoriatic arthritis, and moderate to severe ulcerative colitis.
Bringing to bear his expertise as a life sciences patent litigator with particular experience in acting for plaintiffs and defendants in Hatch-Waxman litigation, the Boston-based Daryl Wiesen heads the IP litigation practice at Goodwin. The practice also enjoys a solid reputation handling technology-related disputes and has a well-known IP appellate team which has recently secured victories in significant Federal Circuit and Supreme Court cases. ITC investigations are another area of strength. Key contacts include Mark Abate, Naomi Birbach and Calvin Wingfield in New York; Boston’s Elaine Blais, Srikanth Reddy, Douglas Kline, and Robert Frederickson; and Patrick McCarthy in Washington DC.
Other key lawyers:
‘Top-notch aptitude (ability to grasp new technologies and systems) along with the ability to walk non-patent in-house counsel through the IP process in an effective and efficient manner.’
Cambridge Mobile Telematics (CMT), State Farm and Liberty Mutual
CommScope, Inc. (acquired original client 2Wire, Inc.)(“2Wire”)
Continental Automotive, Inc.
General Electric Company (GE), Savant & Savant Technologies
Interlude.fm d/b/a eko
International Business Machines Corp (IBM)
Leyard Optoelectronic, Glux Visual Effects Tech, Shenzhen Liantronics, & Unilumin Group
Pass & Seymour
Personalized Media Communications (PMC)
Shenzhen Absen Optoelectronic and Absen Inc. (collectively, “Absen”)
- Achieved a victory for Personalized Media Communications (PMC) in a patent infringement case against Apple.
- Representing plaintiff Novartis in a patent infringement action against Regeneron Pharmaceuticals in the District Court for the Northern District of NY.
- Obtained dismissal of a multi-patent case brought by Thaddeus Gabara against Facebook.
Praised for its ‘tremendous expertise’, Mayer Brown's ‘very knowledgeable team’ enjoys a solid reputation among clients from the technology, electronics, pharmaceutical, medical device, telecommunications, food and beverage, and consumer goods sectors. Skilled in handling patent disputes in the main patent forums, including the PTAB and the ITC, the practice is experience in acting for plaintiffs and defendants. New York's Lisa Ferri is the head of the practice which includes ‘top expert’ Gary Hnath in Washington DC, Richard McCormick in New York, and Jamie Beaber, who impresses with ‘his unique business savvy and sharp team-building skills’, and also operates from Washington DC. The group was reinforced in 2021 with the promotions of Bryan Nese and Manuel Velez.
‘They have a very knowledgeable team, able to support throughout the United States, with tremendous expertise. Very seamless representation.’
‘Gary Hnath is a top expert and was fantastic to work with and with the client. They are top experts which makes them stand out – and they also understand the client’s business.’
‘Jamie Beaber offers a wealth of experience before the US ITC. Jamie is a very trusted advisor, who is hands-on and is deeply involved in the matter that he is working on for us, which gives us great comfort. Not only does he see the big picture of IP practice, but he’s involved in the important details as well.’
‘Gary Hnath is very experienced on various areas of IP consulting service aiming the client’s interest as the top priority, even sacrificing his own time.’
‘Mayer Brown has a very professional team, they have a lot of experience in dealing with different cases. They always propose different solutions for discussion. On the other hand, they organize a smaller team to lower cost, we are very satisfied by both of their knowledge and kindness. Very easy to collaborate, we will definitely recommend Mayer Brown to our friends.’
‘Gary Hnath is the key person. He is very fast, easy to communicate, full of knowledge and experience. He is very reliable, we are always confident that he is our best choice.’
Bristol Myers Squibb
Nestlé USA, Inc/Nespresso
Gemalto (Thales Group)
Nestlé Health Sciences
Philips Electronics North America Corp.
LG Electronics, and LG Display
Maxell Ltd. (formerly Hitachi Maxell)
Mitsubishi Electric Corporation
- Representing Gilead Sciences in Hatch-Waxman patent litigation against fourteen different defendants groups filed in the District Court for the District of Delaware and in the District Court for the Northern District of West Virginia.
- Representing Alexion Pharmaceuticals, Inc. in a patent infringement suit filed by Chugai Pharmaceutical Co., Ltd. in the District Court for the District of Delaware.
- Representing Maxell in patent litigation case involving eight patents directed to various features of televisions.
Offering a mix of law, science, and engineering expertise, the patent litigation practice at Morgan, Lewis & Bockius LLP regularly litigates on behalf of clients in federal courts, before the US Court of Appeals for the Federal Circuit, the ITC, and has a steady track record before the PTAB handling appeals, reexaminations, reissue applications, and IPRs. The life sciences disputes practice is co-headed by Krista Vink Venegas and Michael Abernathy in Chicago, while a trio comprised of Michael Lyons in Silicon Valley, Chicago’s Jason White and John Gorman in Wilmington steers the technology litigation practice, which attracts leading names in the market. Other noted litigators from the group include Eric Kraeutler and Julie Goldemberg in Philadelphia, and Natalie Bennett in Washington DC.
Alfred E. Mann Foundation for Scientific Research
Baxalta (affiliate of Takeda Pharmaceuticals)
Ferrari S.p.A and Scuderia Ferrari S.p.A
Zebra Technologies Corporation
NetScout Systems, Inc.
Milwaukee Electric Tool Corp.
Techtronic Industries Co. Ltd.
- Secured a victory for Alfred E. Mann Foundation for Scientific Research when the US Supreme Court refused to review the US Court of Appeals for the Federal Circuit’s judgment against Cochlear in a patent infringement case dating back to 2007.
- Secured a significant appellate victory on behalf of Takeda’s affiliate Baxalta against Genentech and its drug Hemlibra®, a bispecific antibody for the treatment of hemophilia A.
- Secured an appellate win for ConocoPhillips before the US Court of Appeals for the Federal Circuit following an appeal from the PTAB.
Morrison Foerster houses a renowned IP practice with proven credentials in the technology and life science sectors, considered by some as the ‘go-to team for high-stakes patent litigation’. The team garners additional praise for offering advice which is ‘precise like an accurate watch’, and for being able to understand ‘the smallest technical issues, to the extent they can have direct discussion with key engineers and technical people’. The group is active in the US’ main patent litigation forums, including the ITC and the PTAB, and includes key practitioners Richard Hung, the San Francisco-based co-chair of the litigation team; Los Angeles' Bita Rahebi, a regular advisor to leading technology companies; and the San Francisco-based Michael Jacobs, who earns praise as ‘one of the most experienced patent trial attorneys in the country’.
Other key lawyers:
‘The teams are agile, but also capable of scaling up quickly for broad scope multi-disciplinary litigation across multiple jurisdictions.’
‘Richard Hung is creative and strategic. A strong litigator with solid business acumen.’
‘Michael Jacobs is one of the most experienced patent trial attorneys in the country. You can always count on Michael for complex high-stakes patent litigation.’
‘The team is able to understand the smallest technical issues, to the extent they can have direct discussion with key engineers and technical people.’
‘Their legal advice is precise like an accurate watch. Highly experienced team with broad knowledge of law, able to flexibly and rapidly proposed creative solutions to cope with difficult and intricate situations that change according to the dynamics of the negotiations and the business environment.’
‘The team has a highly sophisticated technology knowledge base. Great diversity on team from associate to partner level. The go-to team for high-stakes patent litigation.’
‘Richard Hung’s rare combination of technical and legal expertise and writing excellence give him that unique ability to manage all aspects of a litigation as well as shine at court.’
Chugai Pharmaceutical Co. Ltd.
San Diego County Regional Airport Authority
Palo Alto Networks
NortonLifeLock Inc. (f.k.a. Symantec Corporation)
- Representing Teradata in a case against SAP involving patent infringement, trade secret misappropriation, and antitrust violations.
- Secured a victory in the Federal Circuit for VMware in an ongoing high-profile patent infringement lawsuit involving virtual system optimization software filed by Cirba Inc. and Cirba IP in the U.S. District Court of Delaware.
- Representing Seagen in a dispute with Daiichi Sankyo, which seeks to hold Daiichi to the terms of the parties’ collaboration agreement and obtain an assignment of Daiichi “Improvements” to Seattle Genetics’ technology.
Orrick, Herrington & Sutcliffe LLP fields a ‘knowledgeable and dedicated team of brilliant attorneys’ who are jointly led by Sten Jensen in Washington DC and Jared Bobrow in Silicon Valley. The team, which is well known for its outstanding PTAB practice, as well as for its broad district court and ITC experience, covers virtually all areas of technology, with a particular focus on semiconductors, networks, software, and consumer electronics technologies. The group is still successfully representing Sonos in its patent infringement litigation against rival Google. Other key names include Washington DC's, Vann Pearce and Steven Routh, who is considered an ‘excellent negotiator’, and Clement Seth Roberts (San Francisco) and Alyssa Caridis (Los Angeles), who are recommended for their ‘great client-service mindset, strong litigation chops, and willingness to have frank discussions even when the news is bad’.
‘When I work with Orrick, I always get a knowledgeable and dedicated team of brilliant attorneys that is structured and managed well. They know how to use technology to benefit their clients and are always willing to negotiate billing arrangements to make a matter work.’
‘Strong subject matter expertise, technical abilities, and strategic litigation perspective. High leverage means lots of resources to throw at sprawling, expansive cases. Clem Roberts and Alyssa Caridis — great client-service mindset, strong litigation chops, and willingness to have frank discussions even when the news is bad.’
‘We have been a long-term relationship with Orrick. Steven Routh and Sten Jensen are excellent lawyers and negotiators.’
Boasting a combined strength in district court, PTAB, Federal Circuit and ITC, Venable LLP stands as the IP counsel of choice for prominent companies in the life sciences and electronic sector, counting long-term clients like Canon and notable names from the pharmaceutical industry such as Novartis or Currax Pharmaceuticals among its client roster. The practice comprises seasoned trial lawyers, including the New York-based Dominick Conde and the Washington DC-based Justin Pierce as heads of the IP division; and technology litigation specialists Frank Gasparo, Michael Sandonato (both in New York) and Megan Woodworth (in Washington DC). Frank Cimino, who focuses on electronics, software, communications, and automotive technologies, is another name to note.
Dominick Conde; Justin Pierce; Frank Gasparo; Michael Sandonato; Megan Woodworth
FCA US LLC
Urschel Laboratories, Inc.
Schaeffler Group USA Inc.
Novartis Pharmaceuticals Corporation
Currax Pharmaceuticals LLC
Prudential Financial Inc.
Candid Care Co.
- Managed claims on behalf of FCA US in the ITC seeking to exclude certain motorized vehicles made and sold by Mahindra & Mahindra Ltd of India and Mahindra Automotive North America, Inc. (sold under the name “Roxor”).
- Representing Melinta and its subsidiaries in ANDA litigation regarding Nexus’s proposed generic version of Melinta’s injectable Minocin antibiotic.
- Filed multiple lawsuits on behalf of Novartis Pharmaceuticals Corp. against multiple companies for infringing patents covering Entresto®.
Life sciences and technology expert Edward Reines, and Elizabeth Weiswasser, a skilled biopharma litigator with a broad experience handling patent cases for pharma and biotech companies, co-head the practice at Weil, Gotshal & Manges LLP. The firm has a solid presence in Silicon Valley, Houston, New York, and Washington DC as well as strong cross-border capabilities. The department has a good track record of PTAB proceedings as well as before the Federal Circuit, and is enjoying an increasing number of successes at the ITC. Additional expertise comes from Silicon Valley's Anne Cappella and Derek Walter, with the latter being particularly well-versed in the life sciences space; and Anish Desai in New York. In 2021 Brian Ferguson in Washington DC and Houston-based partners Garland Stephens and Doug McClellan left the practice, with the latter retiring.
Johnson & Johnson
LiquidPower Specialty Products, Inc.
- Secured a victory before the ITC for Regeneron when competitor Novartis withdrew its patent infringement case seeking to prevent Regeneron from selling its most important drug product in the US.
- Secured an initial determination at the ITC finding that Intuitive Surgical is violating J&J’s patent rights and would be ordered to cease and desist sales of its robotic surgical staplers in the US.
- Won a jury verdict in Delaware federal court for ArcherDX in a competitor patent infringement dispute with Qiagen.
Winston & Strawn LLP offers a bench of ‘very capable trial lawyers across the board’, who have garnered a solid reputation over the years as one of the top patent defense trial shops. The practice stands out for its solid expertise handling cases from a wide range of sectors, including life sciences, pharmaceutical and technology, and maintains a strong presence near the major litigation venues thanks to its offices in Chicago, New York, Washington DC and its California and Texas hubs. The team, which is jointly led by Chuck Klein in Washington DC, and David Enzminger in Los Angeles, was notably reinforced in January 2022 with the arrival of Brian Ferguson, former department co-head at Weil, Gotshal & Manges LLP. Pharma expert George Lombardi and Thomas Melsheimer are other key names.
‘Very capable trial lawyers across the board.’
‘Tom Melsheimer is an exceptional trial lawyer with great skill and ability.’
‘The team is incredibly organized and strategic. They are effective at taking complex issues and clearly laying them out before the judge.’
‘George Lombardi has a strong depth of knowledge and experience. He stand out as top notch patent litigator.’
‘They combine a deep litigation bench with very client counseling and a deep science background. We get great advise that we can trust.’
‘Good depth of knowledge regarding patent enforcement matters. Build a good team to approach each litigation matter.’
‘The Winston team we work with is excellent because they are unique. They combine a deep litigation bench with very client counseling and a deep science background. We get great advice that we can trust.’
‘What makes the people at Winston we work with stand out is their ability to understand our needs and provide counseling and advice that we can rely on because it’s tailored to our business and our goals.’
Take-Two Interactive Software, Inc.
Contour IP Holdings
Schlumberger/Smith International / M-I LLC/Cameron International Corp.
Hikma Pharmaceuticals USA Inc.
Sunoco / Energy Transfer Partners
Magnolia Pictures LLC
SAP America, Inc.
Teva North America
Associated British Foods
Indoco Remedies Limited
- Represented M-I LLC, a Schlumberger Ltd. subsidiary, in the defense of three patents for vacuum-assisted shale shaker technology.
- Obtained a victory for Take-Two Interactive Software in a patent infringement case involving Grand Theft Auto and NBA 2K, two of the most popular video games of all time.
- Secured a victory for Sandoz, which invalidated a patent protecting Amgen’s blockbuster psoriasis drug, Otezla® (apremilast), which generates approximately $2 billion in annual sales.
Cravath, Swaine & Moore LLP fields a group of ‘superb trial lawyers with a long track record in dealing with complex patent litigation’, who are particularly well-versed in the life sciences, ‘including biologics and technology’, medical devices and telecommunications sectors. New York-based practitioners Keith Hummel, who has a ‘particular expertise in handling complex, often multi-jurisdictional patent disputes’, and Sharonmoyee Goswami are the key contacts of the practice, which brings to bear its extensive transactional expertise, and is also a solid choice for commercial litigation frequently arising from IP matters, such as antitrust and breach of license claims. Richard Stark retired in December 2021.
‘The firm has superb trial lawyers with a long track record in dealing with complex patent litigation. It is particularly known for handling complex often multi-jurisdictional litigation in relation to medical devices, life sciences including biologics and technology.’
‘Keith Hummel is a superb lawyer with a particular expertise in handling complex, often multi-jurisdictional patent disputes. He is exceptional at complex patent matters. He is frequently called in to coordinate multi-jurisdictional patent disputes. He is incredibly knowledgeable, creative and pragmatic and an absolute pleasure to work with.’
‘Keith Hummel is incredible – he brings unique and effective insights to every issue, he effectively communicates internally and externally, and he delivers high-quality results without exception.’
‘Everyone from partners to associates are fantastic, highly responsive and deliver quality insights and work product.’
‘Among other talents, they have a gift for simplifying seemingly complex issues and crafting a path to a successful solution. When stakes are high in a patent case, Cravath is the team to engage.’
‘For individuals who stand out, I think of Keith Hummel.’
Axalta Coating Systems, LLC
Blue Yonder Group, Inc.
Quibi Holdings, LLC
Vitaworks IP, LLC
- Representing Abiomed in two patent infringement matters relating to patents for guidance systems used to place intravascular blood pumps.
- Representing Axalta Coating Systems, LLC in patent infringement litigation filed by PPG Industries Ohio, Inc. and PPG Industries, Inc. alleging that Axalta infringes a PPG patent claiming a three-layer coating system.
- Representing Vitaworks as plaintiff in patent litigation against several entities alleging infringement of 11 Vitaworks patents for improved methods of manufacturing taurine.
Fenwick & West LLP
According to a client, Fenwick & West LLP ‘sets a gold standard for patent litigation’. The San Francisco-based Michael Sacksteder steers the team, which has an impressive track record in federal jurisdictions throughout the US, as well as before the Patent Office on parallel reexamination proceedings, recently notching up significant victories for tech giants, including Google, as well as for pharma and life sciences clients such as Novo Nordisk and UCB. The gaming sector is another key area of expertise for the practice. With offices in New York, Seattle and Mountain View and noted practitioners David Hadden, the ‘excellent’ Ravi Ranganath (elected to partner in early 2021) and Saina Shamilov; and Kevin McGann, a ‘strong trial lawyer’ with a proven expertise in technology and life sciences litigation, the group has a solid US presence.
Other key lawyers:
‘Fenwick sets a gold standard for patent litigation. They understand technology and patent law as well as, or better than, anyone in the industry. They can position a case for trial appropriately, win it at trial for you, defend that win on appeal for you, and maybe get your fees to boot.’
‘David Hadden is a genius. Ravi Ranganath and Saina Shamilov are also excellent.’
‘Strong bench of folks from junior associates to the senior partner level. Team uses lean staffing (only seeking to add new members where complexity/work loads require).’
‘Kevin McGann – strong trial lawyer. Fast on his feet and always prepared for everything at argument.’
Avalyn Pharma, Inc.
National Products, Inc.
- Defended Google Maps against claims of patent infringement brought by the plaintiff, Sholem Weisner, who originally asserted a single location-tracking patent but later amended his complaint to assert four patents.
- Obtained a very favorable settlement in a contract dispute lawsuit on behalf of AnaptysBio that resulted in an amended immuno-oncology collaboration agreement with GlaxoSmithKline (GSK).
Well-established IP boutique firm Knobbe Martens Olson & Bear LLP operates from its offices in in Los Angeles, New York, Orange County, San Diego, San Francisco, Seattle and Washington DC, providing comprehensive IP services to clients across the country before the federal and state courts, the ITC, in Patent Office proceedings, as well as before international forums. The firm has a strong life sciences litigation practice, with a high rate of success handling Hatch-Waxman litigation, and a balanced mix of cases for IP holders and defendants. Irvine’s Sheila Swaroop and Michael Friedland have recently taken the reins of the team, which includes William Zimmerman, who has a stellar record in Hatch-Waxman litigation; and ANDA experts Carol Pitzel Cruz and Joseph Reisman. Jeremiah Helm, promoted to partner in January 2021, is another name to note. Clients include Monster Energy, Smith & Nephew, Nobel Biocare, Fisher & Paykel, and Edwards Lifesciences Corporation.
Other key lawyers:
‘The team is highly experienced on a national basis in addressing infringement of US patents. This includes a strong list of local litigation contacts in each state. Their expertise gained over time has resulted in broad recognition of Knobbe Martens as a leader in the patent litigation space.’
‘Ali Razai has been a strong team lead. He is experienced in patent enforcement programs, and is very familiar with all of the tools available to conduct such enforcement. He has been a strong guide in our efforts to formulate our own patent enforcement policies and programs.’
‘Accommodative lawyers who are available for the clients make this firm unique. They support by giving most appropriate advice. They are open for suggestions but will not do a thing only because the client says so, when they know it is not appropriate.’
Monster Energy Company
Fisher & Paykel Healthcare Ltd.
Edwards Lifesciences Corporation
Smith & Nephew, Inc.
Razor USA LLC
Nobel Biocare USA, LLC
Intellectual Ventures Management, LLC
Applied Medical Resources Corp.
Skyworks Solutions, Inc.
Personal Genome Diagnostics, Inc.
Lund Motion Products, Inc.
- Achieved a successful result for Toshiba in a patent infringement matter.
- Representing Co-Plaintiff Edwards Lifesciences in a high-profile case challenging the Director of the US Patent Office’s authority to set the NHK-Fintiv rules for discretionary denial of a Petition for inter partes review when co-pending litigation has an early trial date.
- Defended Inogen against a competitor’s claims of patent infringement, breach of contract, and various related torts.
McDermott Will & Emery LLP has added bench strength to its West Coast capabilities with the arrival of Douglas Carsten; a skilled litigator with a good record in the life sciences IP arena formerly at Wilson Sonsini Goodrich & Rosati. The ‘exceptional team’ has also bolstered its East Coast life sciences practice with the arrival of DC-based partner Adam Burrowbridge, who also joined from Wilson Sonsini Goodrich & Rosati, Silicon Valley’s William Gaede heads the group, which remains a one-stop-shop for clients thanks to its full range of patent litigation expertise, which they put to use not only at state level, but also nationally and globally. Praised for developing ‘innovative solutions’, the practice boasts an excellent reputation in the healthcare, pharmaceuticals and biotechnology space, as evidenced by its client roster, which includes names such as Amgen, Mylan Pharmaceuticals, and United Therapeutics. Sarah Chapin Columbia in Boston; Thomas Steindler, who leads the IP litigation group in Washington, DC; Chicago’s Charles McMahon; Shane Nichols in Atlanta, who holds a degree in electrical engineering; and Mandy Kim in Orange County, who extensive ITC experience, are other key members of the department. Nicole Jantzi and Paul Schoenhard left in January 2022.
Other key lawyers:
‘An exceptional team which develops innovative solutions that align with our business needs and is not solely focused on the litigation at hand. Open to taking a holistic approach when developing a litigation strategy.’
‘The team is very responsive and creative. We were able to put together a strong patent strategy quickly.’
‘I appreciated their deep expertise and the time they spent getting to know our products and services. It was great to work closely with them and get things rolling quickly.’
‘Sarah Columbia is an excellent patent trial lawyer. Loved her lack of ego and laser focus on the nuances of jury trials and greatly valued her robust trial experience.’
Bausch Health US
Feit Electric Company
Mallinckrodt plc and Mallinckrodt Pharmaceuticals
Mylan Pharmaceuticals Inc./Mylan GmbH
Next Caller Inc.
Novartis Pharmaceuticals Corporation; Novartis Vaccines and Diagnostics, Inc.
Roper Technologies, Inc.
Serta Simmons Bedding, LLC
Suteng Innovation Technology, Co., Ltd. a/k/a RoboSense
The Coca-Cola Company
Traeger Pellet Grills LLC
Way Interglobal Network, LLC
ZTE (USA), Inc.
- Representing Amgen in its long-fought battle with Sanofi and Regeneron Pharmaceuticals over the new generation of blockbuster drugs proven to lower ‘bad’ cholesterol (LDL).
- Secured a PTAB victory for Mylan in its battle against Sanofi related to its efforts to provide a lower cost alternative to Sanofi’s Lantus SoloSTAR insulin glargine product.
- Represented ZTE in its ongoing battle with Evolved Wireless, LLC, related to LTE cellular technology.
McKool Smith's practice earns plaudit for ‘excellent chemistry as a team’ and for its group of attorneys that are ‘at the top of their game’. The group is mostly based in the firm's Austin, Dallas, and Marshall offices, but its national footprint also includes New York, Washington DC and Los Angeles. The practice is well-known for its extensive expertise handling patent disputes and its considerable ITC experience. The practice, which is led by David Sochia, routinely acts for clients from the telecoms, technology, and electronics sectors. Sam Baxter, Douglas Cawley, Nicholas Mathews, and Warren Lipschitz are otherkey contacts. Theodore Stevenson left the firm in June 2021.
‘McKool Smith has an excellent chemistry as a team. They are all about the case and no egos. Their communication with their clients is always excellent.’
‘I have not a doubt in my mind that the each attorney at McKool Smith is at the top of their game. Their knowledge and communication of that knowledge makes managing the risks of a particular case very easy.’
Palo Alto Research Center
Dr. Ford Albritton
Sanofi and Regeneron
Taiwan Semiconductor Manufacturing Company
- Acted as co-counsel securing a $300m patent damages verdict on behalf of Optis Wireless Technology, Optis Cellular Technology, Unwired Planet, Unwired Planet International Limited, and PanOptis against Apple.
- Represented Rovi/TiVo in three ITC investigations regarding its long-running dispute with Comcast.
- Represented various Sanofi entities and Regeneron Pharmaceuticals in patent infringement litigation regarding the companies’ novel biologic Dupixent®.
Widely known for its first-class capabilities in life sciences litigation, Milbank is particularly active at the intersection of pharma patent litigation and FDA and FTC issues, including in negotiating complex settlements in Hatch-Waxman cases. Pharmaceuticals, biotechnology, and medical devices companies turn to the practice led by David Gindler, a ‘formidable trial lawyer’ based in Los Angeles, who is also skilled at handling licensing disputes. Also operating from the West Coast are Gary Frischling, Lauren Drake and Yite John Lu, while the New York presence is covered by Christopher Gaspar and special counsel Nathaniel Browand. Errol Taylor retired from the firm on November 2020, and became a consulting partner. Technology, electronics and semiconductor sectors as other core focus areas of the team.
Other key lawyers:
‘David Gindler, who leads Milbank’s IP litigation, is widely recognized by peers and clients as operating in the very top-tier of litigators and trial lawyers in the patent world. He is an exceptional legal writer and a formidable trial lawyer.’
‘Very strong commitment to diversity.’
‘I’ve really appreciated working with John Lu.’
Tris Pharma, Inc.
TMT Systems, Inc.
Rosenberger Technology (Kunshan) Co. Ltd., Rosenberger Asia Pacific Electronic Co., Ltd., Rosenberger Site Solutions, LLC
Ludwig Institute for Cancer Research
Unicorn Energy GmbH
Take-Two Interactive Software, Inc.
MRSI Systems, Inc.
Emeram Capital Partners
Boards and More GmbH
EB Research Partnership (EBRP)
Fujitsu Network Communications, Inc.
- Secured a victory on behalf of Tris Pharma in a lawsuit against Actavis on patents covering Tris’ Quillivant XR® product, the first liquid long-acting treatment for ADHD.
- Represented Fujitsu Network Communications (FNC) in the defense of a patent infringement complaint by Capella Photonics, Inc. against FNC (E.D. Tex.).
- Representing Genentech in a dispute with its competitor Novartis regarding approximately $210m in licensing payments.
Well-known for its strong cross-border capabilities and recommended for its ‘solid legal and technical skills from top to bottom’, Norton Rose Fulbright is comfortable litigating in all US patent venues, with a particularly solid reputation in the Western District of Texas and a booming PTAB practice. The disputes team is since 2021 headed by Houston-based Daniel Leventhal, a high-tech patent litigator with a particular focus on telecommunications, electronics, and internet. His versatile team includes other noted practitioners such as Richard Zembek, global head of technology and also based in Houston; and Brett Govett and Stephanie DeBrow, both praised for being ‘exceptionally skilled lawyers that provide superb results’, and who operate from Dallas and Austin respectively.
‘Solid legal and technical skills from top to bottom, throughout the entire team. Exceptional responsiveness and efficiency.’
‘Brett Govett, Daniel Leventhal, and Stephanie DeBrow are exceptionally-skilled lawyers that provide superb results within sometimes challenging budget constraints.’
Palo Alto Networks, Inc.
Sanyo Electric Co. Ltd.
The General Electric Company
Walmart Inc. and its affiliate Sam’s Club
- Co-counsel in defending Qualcomm in a case brought by the FTC in which the Ninth Circuit threw out the antitrust ruling against Qualcomm.
- Representing Match Group in a three patent suit directed to implementing and managing efficient and effective data communications over networks and improving the utility of information services.
- Representing Phillips 66 as defendant in the lawsuit filed by patent owner Magema for infringement of four patents related to the production of marine fuel oil used by large ocean vessels.
O’Melveny & Myers LLP‘s practice maintains a strong foothold in the main US patent litigation venues, with a focus on hardware to software, augmented reality to streaming video, e-commerce and digital technology to pharmaceuticals, acting on the defense and offense side alike. The group also handles an active Hatch-Waxman and BPCIA caseload. In 2021 the firm expanded its footprint into Texas, opening two new offices in Austin and in Dallas, and added two new partners to its ranks, Tim Durst from Baker Botts L.L.P., and Tim Fink from the USPTO, who leads the PTAB practice. Practice head Ryan Yagura is based in Los Angeles. His team includes San Francisco trio Darin Snyder, Luann Simmons and David Almeling; and New York’s Lisa Pensabene, who heads the life sciences litigation practice. Counsel Mark Liang, also in Los Angeles, is another name to note.
Advanced Micro Devices (AMD)
Clear Channel Outdoor
Hyundai Motor America and KIA Motors America, Inc.
Samsung Electronics Co., Ltd.
- Secured a victory for Google in a patent infringement case relating to digital picture frame technology.
- Representing Onyx Therapeutics (an Amgen company) in Hatch-Waxman patent litigation involving the multiple myeloma cancer drug Kyprolis®.
- Represented Hulu against patent infringement claims involving video-on-demand technology.
Ropes & Gray LLP's team of skilled IP attorneys is split across the country in key strategic legal centers in Silicon Valley, San Francisco, New York, Boston, and Washington DC. The group frequently acts before all major patent litigation forums, but is particularly distinguished for its remarkable PTAB practice headed by seasoned litigator Scott McKeown. Garnering praise for offering ‘unique ideas’, the department is well known for its strength in the semiconductor, electronics, telecoms and manufacturing sectors. It is also steadily gaining a foothold in the life sciences sector, with a busy biopharmaceutical and medical device practice managed by a ‘fantastic team’ comprised of Filko Prugo and Charlotte Jacobsen, who have a focus on Hatch-Waxman litigation. Kevin Post and Matthew Rizzolo, who are ‘deeply versed in the relevant technologies’; James Batchelder; and practice head Andrew Thomases are the other key contacts.
Other key lawyers:
‘I have been impressed by the Ropes & Gray team and their knowledge and genuine interest in the pharmaceutical space. They consistently present unique ideas.’
‘Filko Prugo and Charlotte Jacobsen are a fantastic team. They work together and complement each other so as to present a well-rounded and knowledgeable team.’
‘Kevin Post and Matt Rizzolo understand patent litigation. They are deeply versed in the relevant technologies. They are precise and effective in scoring points. Judges learn to trust this team, because they present the law and facts directly and accurately.’
‘Kevin Post has a low-key way of delivering powerful arguments so that judges believe him. Matt Rizzolo scores points with strong legal and factual citations delivered with passion.’
Cellink Life Sciences
CJ CheilJedang Corp.
Dolby Laboratories, Inc.
Emerson Electric Co.
RAB Lighting, Inc.
SAP America, Inc.
Tristar Products, Inc.
- Representing BorgWarner in a patent litigation against competitor Schaeffler relating to variable cam timing technology for automotive engines.
- Representing Emerson Electric in its long-running international dispute against SIPCO concerning Emerson’s Smart Wireless products.
- Represented IP Bridge in a district court trial and Federal Circuit appeal adverse to TCL Communication and various TCL subsidiaries, which resulted in a precedential ruling with significant implications for future cases of a similar nature.
Akin Gump Strauss Hauer & Feld LLP offers a prominent patent litigation practice, which shows particular strength in the life sciences, representing both plaintiffs and defendants, and advising big names in the industry such as Johnson & Johnson, Boston Scientific, and 3M. In addition, the group also represents major technology and electronics companies, maintaining a steady activity in federal courts, the ITC and the PTAB. Philadelphia’s Steve Maslowski steers the practice, which also operates from its patent hubs in Washington DC with Cono Carrano and Brandon Rash; New York with Michael Kahn; and Irvine with Kevin McBride. This last office was reinforced in 2021 with the arrival of Paul Tripodi from Wilson Sonsini Goodrich & Rosati. Texas-based associate Andy Rosbrook is another name to note.
Other key lawyers:
Boston Scientific Corporation
Bristol-Myers Squibb Co.
Ethicon Endo-Surgery, Inc.
George Strait Productions, Inc.
Helen of Troy
Inguran d/b/a STgenetics (formerly Sexing Technologies)
Johnson & Johnson Consumer Inc.
Merck & Co., Inc.
Minerva Surgical, Inc.
Newfield Exploration Company
Ono Pharmaceutical, Ltd.
Pratt & Whitney
Raytheon Technologies (formerly United Technologies Corporation)
Signify Holding B.V.
- Representing Boston Scientific in a patent infringement and trade secret misappropriation case against Nevro Corp. in the District of Delaware.
- Representing XY, LLC in a patent infringement suit against their competitor Trans Ova in the US District Court for District of Colorado arisen from alleged infringement of five patents relating to mammalian gender selection and flow cytometry.
- Achieved a victory at the PTAB for Janssen Pharmaceutica NV (a unit of J&J), which denied institution of an inter partes review (IPR) petition brought by Mylan against Janssen.
Schiff Hardin LLP and Arent Fox LLP now operate under the ArentFox Schiff brand, following the merger of the two firms which became official in March 2022. The union will increase the team's reach from Chicago to other key markets, including Washington DC, New York, and Los Angeles, and will also reinforce the already outstanding capabilities in Hatch-Waxman litigation. The practice, co-headed by Imron Aly and Sailesh Patel, represents renowned generic pharmaceutical companies such as Fresenius Kabi or Nexus Pharmaceuticals and has an extensive record in handling ANDA patent litigation and 505(b)(2) applications. The group is particularly skilled handling matters related to patentability, inherent anticipation, and obviousness. Chicago-based practitioners Kevin Nelson, Joel Wallace, and associate Helen Ji are other noted names of the department.
‘The team is exceptionally experienced with trials (not just pre-trial work). Many of their partners have first chair trial experience and have taken on lead roles at trials. In addition, the team has also introduced unique capabilities to help estimate litigation costs for every stage of litigation, which provides the clients with an opportunity to accurately forecasts legal expenses each month/quarter.’
‘The firm values diversity and ensures the appropriate recruitment for underrepresented minorities and women.’
‘Imron Aly is one of the strongest patent litigators I have every worked with. Imron’s scientific knowledge combined with his ability to discredit expert witnesses during depositions and trial are particularly valuable. He works closely with clients on all aspects of trial and has a comprehensive appreciation for the pharmaceutical industry, regulatory requirements, manufacturing, and licensing implications – all of which help with developing an IP strategy.’
Ajanta Pharma Ltd
Akorn Pharmaceuticals, Inc.
Alkem Laboratories Ltd.
Aurobindo Pharma Ltd.
HCL America, Inc.
Intas (Accord) Pharmaceuticals
Safety Vision LLC
Gland Pharma Ltd.
- Representing Safety Vision in a patent infringement matter involving three patents relating to a vehicle video monitoring system.
- Representing Aurobindo, who is seeking to introduce a generic version of Pfizer’s IBRANCE® (palbociclib) product.
- Leading Nexus’s efforts to stop compounding companies who sell unapproved versions of Nexus’s FDA-approved ready-to-use ephedrine sulfate product.
The practice at Baker & Hostetler LLP is well known for its patent litigation capabilities acting before the Court of Federal Claims, showcasing its combined expertise in IP and government contract law. The group also holds a solid reputation and presence in other US venues, including the PTAB, the ITC, and the federal circuit, and while it shows a particular strength in the technology sector, it skillfully acts in a wide gamut of industries. Comcast, HP, L3 Harris Technologies, and Crown Holdings, are among the group’s client roster. Daniel Goettle in Philadelphia, Kevin Kirsch in Cincinnati/Columbus, and Leif Sigmond in Chicago and Philadelphia’s John Murphy are key names. Katrina M. Quicker left the firm in February 2021.
Comcast Cable Communications, LLC
Showa Glove Co.
PL Developments, Inc.
PuraCap Pharmaceutical LLC
Smart Communications Holding, Inc
Cardinal Health, Inc.
Henny Penny Corporation
L3 Harris Technologies, Inc.
AT&T/AT&T Services Inc.
Guest-Tek Interactive Ltd.
Trading Technologies International, Inc.
Trustwave Holdings, Inc.
Dechert LLP‘s practice garners praise for being ‘technically sophisticated, smart, transparent, and ethical’. The group headed by Philadelphia’s Martin J Black , which is able to ‘identify strengths and weaknesses as cases mature’, regularly acting on the plaintiff’s side, has a particular strength in the life sciences sector with a dedicated Hatch-Waxman litigation team. The New York-based Katherine Helm has a focus on pharmaceutical and biotech patent litigation. In 2021 Howard Levine and Jennifer Swan joined from Finnegan, Henderson, Farabow, Garrett & Dunner LLP. Silicon Valley’s Nisha Patel left the firm for an in-house position.
Other key lawyers:
‘The Dechert IP team is technically sophisticated, and they understand how to put together a winning offensive patent case that brings maximum pressure to bear on a defendant as the case matures. They also understand how to lead settlement negotiations to optimize client recovery.’
‘The Dechert IP team is smart, transparent, and ethical. They identify strengths and weaknesses as cases mature and they provide candid guidance to lead their clients to good outcomes.’
BioDelivery Sciences International (BDSI)
Boston Scientific Corporation
Eli Lilly and Company
Kymera Therapeutics Inc.
Mondis Technology, Ltd., Hitachi Maxell, Ltd.
- Representing Eli Lilly and Company in global patent litigation and European Patent Office proceedings involving Novartis Pharma AG, which acquired and has been enforcing the Genentech patent portfolio against Lilly’s blockbuster antibody therapeutic Taltz® (ixekizumab).
- Advising Hitachi and Mondis Technology on a licensing and litigation campaign that has led the major players in the computer display and television industries to take licenses of the patents formerly owned by Hitachi and now owned by Mondis.
- Successfully represented Boston Scientific in a patent infringement suit involving multiple patents relating to endoscopic hemostasis clips.
Durie Tangri LLP
Boutique firm Durie Tangri LLP impresses with a group of ‘very smart lawyers’ which operates from its offices in San Francisco and Los Angeles. Daralyn Durie, an ‘exceptional’ attorney who garners praise for her ‘commanding demeanor that wins with intellect and passion rather than histrionics’, heads the practice together with Mark Lemley. The group represents companies in cases ranging from biotechnology to e-commerce, solar technology to firewalls. Other key practitioners include Kira Davis, who has a particular experience representing pharmaceutical, medical device, and other life sciences companies, and reinforced the LA office in 2020; and Eugene Novikov in San Francisco.
‘Very smart lawyers, and they keep their teams very lean. Easy to work with – very responsive and proactive. Always keep the bigger picture in mind. They also partner well with other law firms, which is not always the case.’
‘Daralyn Durie is exceptional. She can quickly break down issues so that lawyers and non-lawyers alike understand. She works well with the business. In the courtroom, she has a commanding demeanor that wins with intellect and passion rather than histrionics.’
‘Very good folks who are strong advocates. They produce good and timely work product, and they summarize complex issues clearly and succinctly. Reasonably priced.’
‘The whole team at Durie is top notch.’
Epic Games, Inc.
10x Genomics, Inc.
Antech Diagnostics, Inc. et al
City of Hope
- Secured a verdict on behalf of Berkeley-based Plexxikon in a patent infringement lawsuit against Novartis Pharmaceuticals Corporation.
- Successfully represented Genentech in two patent office proceedings brought by Merck Sharp & Dohme Corp. seeking to have two key Genentech patents invalidated.
- Representing Epic Games, Inc. in litigation brought by Utherverse Gaming LLC for allegedly infringing four patents related to the idea of ‘instancing’—a concept in multiplayer games.
Greenberg Traurig, LLP‘s patent litigation team handles cases around the country, regularly acting in district courts, appellate courts, as well as before the International Trade Commission. The group shows prowess in a variety of sectors, particularly e-commerce, technology, electronics, financial services and pharmaceutical. New York-based practitioners Scott Bornstein, Allan Kassenoff, and Joshua Raskin, who garners praise for being not only an ‘incredibly strong technical lawyer, but also a great tactician and strategic advisor’, are the main contacts of the team.
‘First and foremost, Josh Raskin is an incredible relationship partner.’
‘Josh Raskin is an incredibly strong technical lawyer, but also a great tactician and strategic advisor. He is always available and hyper responsive.’
‘I also have good things to say about associate Vimal Kapadia, who has proven to be very capable and responsive.’
Kretek International, Dryft Sciences, The Art Factory, and TillCe
Amneal Pharmaceuticals LLC
Crye Precision LLC
- Represented Rakuten Kobo Inc. in a patent infringement suit brought by Pop Top Corp. in the District Court for the Northern District of California.
- Secured a victory for Samsung against Prisua Engineering in a patent case before the PTAB and the Court of Appeals for the Federal Circuit.
- Representing Satco in a patent case in the Western District of Texas, securing grant of Satco’s motion to dismiss seven counterclaims filed by Signify.
Silicon Valley’s Jonathan Waldrop heads the team at Kasowitz Benson Torres LLP, which is sought out by defendants and plaintiffs from the technology and life sciences sectors and has a solid track record across the major federal patent venues. The group stands out for its growing presence in the Western District of Texas. The other key names are New York-based attorneys Jay Deshmukh and Hershy Stern, who make up the Hatch-Waxman team and focus on disputes arising from patents covering pharmaceutical products; and California-based duo Darcy Jones and Marcus Barber, who cover a wide range of technologies, including software and telecommunications.
Leader Development Industrial Corp.
- Representing Fintiv in a case against Apple involving a patent that covers the management of virtual cards stored on mobile devices.
- Representing Zydus Pharmaceuticals in two Hatch-Waxman patent infringement actions involving generic versions of diabetic drugs INVOKANA® and INVOKAMET®.
- Represented defendant Reddit against allegations that Reddit, as well as over 100 other Amazon customers, including Airbnb and Square, use Ruby on Rails software implementing the HTTP web protocol as well as Amazon Simple Storage Service (‘S3’), successfully securing summary judgment on non-infringement on behalf of Reddit.